BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35177513)

  • 41. Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?
    Wong ELY; Cheung AWL; Huang F; Chor JSY
    Cancer Nurs; 2018; 41(1):45-52. PubMed ID: 28114260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A conjoint analysis study on self-sampling for human papillomavirus (HPV) testing characteristics among black women in Indiana.
    Biederman E; Champion V; Zimet G
    BMC Womens Health; 2020 Mar; 20(1):55. PubMed ID: 32192493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
    Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
    Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study.
    Hang S; Haruyama R; Uy K; Fujita N; Kimura T; Koum K; Kawana K
    J Gynecol Oncol; 2024 Jan; 35(1):e6. PubMed ID: 37743059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knowledge, Attitude, and Practice of Cervical Cancer Screening, and HPV Vaccination: A Cross-Sectional Study Among Obstetricians and Gynecologists in Egypt.
    Mohamed ML; Tawfik AM; Mohammed GF; Elotla SF
    Matern Child Health J; 2022 Mar; 26(3):565-574. PubMed ID: 35060068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe.
    Joseph J; Mangwendeza P; Maparo T; Mhizha T; Demke O; Murwira S; Dickson H; Madzima B; Khan S
    J Clin Virol; 2021 Dec; 145():105017. PubMed ID: 34715579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results.
    Kraut R; Manca D; Lofters A; Babenko O
    Curr Oncol; 2022 Jul; 29(8):5368-5369. PubMed ID: 36005163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results.
    Lesack A; Smith LW; Racey CS; Gondara L; Krajden M; Lee M; Martin RE; Stuart G; Peacock S; Franco EL; van Niekerk D; Ogilvie GS
    Curr Oncol; 2022 May; 29(6):3860-3869. PubMed ID: 35735417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
    Fujita M; Shimazu M; Nagashima K; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Shozu M; Hanaoka H; Tsuruoka N; Kasai T; Hata A
    BMJ Open; 2022 Feb; 12(2):e049803. PubMed ID: 35115348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
    Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
    Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
    BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-collected versus medic-collected sampling for human papillomavirus testing among women in Lagos, Nigeria: a comparative study.
    Feng N; Ezechi O; Uwandu M; Abimbola BS; Vincent GD; Idigbe I; Okoli LC; Adesina M; Okwuzu J; Ahmed RA; Sokei J; Shaibu JO; Momoh AE; Sowunmi O; Labo-Popoola OH; ; Ohihoin G; David A; Nzeribe E; Olaleye O; Dong XP; Onwuamah CK
    BMC Public Health; 2022 Oct; 22(1):1922. PubMed ID: 36243709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
    Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
    CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of detection sensitivity for human papillomavirus between self-collected vaginal swabs and physician-collected cervical swabs by electrochemical DNA chip.
    Nilyanimit P
    Asian Pac J Cancer Prev; 2014; 15(24):10809-12. PubMed ID: 25605181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 57. Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
    Boggan JC; Walmer DK; Henderson G; Chakhtoura N; McCarthy SH; Beauvais HJ; Smith JS
    Sex Transm Dis; 2015 Nov; 42(11):655-9. PubMed ID: 26462192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador.
    Maza M; Melendez M; Masch R; Alfaro K; Chacon A; Gonzalez E; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M
    Prev Med; 2018 Sep; 114():149-155. PubMed ID: 29958860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Self-sampling as the principal modality for population based cervical screening: Five-year follow-up of the PaVDaG study.
    Stanczuk GA; Currie H; Forson W; Baxter G; Lawrence J; Wilson A; Palmer T; Arbyn M; Cuschieri K
    Int J Cancer; 2022 Apr; 150(8):1350-1356. PubMed ID: 34850395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening.
    Chatzistamatiou K; Vrekoussis T; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moschaki V; Ntoula M; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Daponte A; Vanakara P; Paschopoulos M; Stefos T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Deligeoroglou E; Panoskaltsis T; Adonakis G; Michail G; Stamatopoulos K; Agorastos T
    J Womens Health (Larchmt); 2020 Nov; 29(11):1447-1456. PubMed ID: 32757997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.